Prarthana Kalerammana Gopalakrishna
Prarthana Kalerammana Gopalakrishna publishes mostly in Complementary and alternative medicine, Pharmacology and Physiology, on topics such as Medicinal Plants and Neuroprotection, Alzheimer's disease research and treatments and Neuroinflammation and Neurodegeneration Mechanisms.
- World rank
- #1,662,902 of 7,710,434 ranked researchers
- Rank in Malaysia
- #6,322 of 41,196
- Works
- 16
- Citations
- 140
- Citations per work
- 8.8
What does Prarthana Kalerammana Gopalakrishna research?
Prarthana Kalerammana Gopalakrishna's work is mostly in Medicine (33%), Neuroscience (9%), Pharmacology, Toxicology and Pharmaceutics (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else744.4%
- Health Sciences533.4%
- Medicine533.4%
- Life Sciences317.8%
- Physical Sciences14.4%
- 1Complementary and alternative medicine16% of their works
- 2Pharmacology9% of their works
- 3Physiology9% of their works
- 4Pharmacology9% of their works
- 5Neurology9% of their works
- 6Health, Toxicology and Mutagenesis4% of their works
Research topics
- Medicinal Plants and Neuroprotection
- Alzheimer's disease research and treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological Disease Mechanisms and Treatments
- Natural Antidiabetic Agents Studies
- Autophagy in Disease and Therapy
- Cannabis and Cannabinoid Research
- Cholinesterase and Neurodegenerative Diseases
Which keywords describe Prarthana Kalerammana Gopalakrishna's research?
The keywords of their largest research topics: Alzheimer's Disease, Oxidative Stress, Bacopa monnieri, Centella asiatica, Neurodegeneration, Neuroinflammation, Amyloid Hypothesis and Neurodegenerative Diseases.
- Microglia
- Disease
- Cholinesterase Inhibitors
- Cannabinoid Receptors
- Astrocytes
- Acetylcholinesterase
- Neurodegenerative Diseases
- Neuroinflammation
- Centella asiatica
- Oxidative Stress
- Alzheimer's Disease
- Bacopa monnieri
- Neurodegeneration
- Amyloid Hypothesis
- Tau Pathology
- Antioxidants
- Autophagy
- Cerebral Hypoperfusion
- Diabetes
- Endocannabinoid System
- Vascular Cognitive Impairment
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Alzheimer's Disease82 topics
- Oxidative Stress83 topics
- Bacopa monnieri61 topic
- Centella asiatica61 topic
- Neurodegeneration62 topics
- Neuroinflammation62 topics
- Amyloid Hypothesis41 topic
- Neurodegenerative Diseases42 topics
- Tau Pathology41 topic
- Acetylcholinesterase21 topic
- Antioxidants21 topic
- Astrocytes21 topic
- Autophagy21 topic
- Cannabinoid Receptors21 topic
- Cerebral Hypoperfusion21 topic
- Cholinesterase Inhibitors21 topic
- Diabetes21 topic
- Disease21 topic
- Endocannabinoid System21 topic
- Microglia21 topic
- Vascular Cognitive Impairment21 topic
Where does Prarthana Kalerammana Gopalakrishna work?
Prarthana Kalerammana Gopalakrishna's main affiliation in the publication record is IMU University, Malaysia.
How many publications and citations does Prarthana Kalerammana Gopalakrishna have?
OpenAlex counts 16 works and 140 citations for Prarthana Kalerammana Gopalakrishna, an h-index of 6, ranking #1,662,902 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Prarthana Kalerammana Gopalakrishna. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.